AMAG Pharmaceuticals (AMAG)
18.80
+0.60 +3.30%
NASDAQ
May 26, 20:00
Delayed 2m
USD
View All Key Stats
AMAG Key Stats
| Income Statement | |
| Revenue (TTM) | 562.26M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.95 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -31.52M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 76.64% |
| Profit Margin (Quarterly) | -26.21% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0.00 |
| Price and Valuation | |
| Market Cap | 658.85M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 1.212 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 0.713 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 1.066 |
| Free Cash Flow (Quarterly) | -15.19M |
| Return on Equity (TTM) | -3.40% |
View All AMAG News
AMAG News
-
WireHeadlineTime (ET)
-
Globe Newswire05/16 08:00
-
Yahoo05/15 09:30
-
MT Newswires05/15 08:28
-
Globe Newswire05/15 08:00
-
Yahoo05/15 07:01
-
SA Breaking News05/12 15:01
-
Yahoo05/12 14:06
-
Yahoo05/10 08:55
-
Globe Newswire05/10 08:00
-
Yahoo05/05 15:47
View All Events
AMAG Events
| Date | Type | Description |
|---|---|---|
| 05/24/2017 08:30 EDT | Misc | AMAG Pharmaceuticals to Host Analyst Day on May 24th in New York |
| 05/24/2017 08:30 EDT | Misc | AMAG Pharmaceuticals, Inc. Analyst Day |
| 05/02/2017 08:00 EDT | Misc | AMAG Pharmaceuticals Inc First Quarter Earnings Conference Call in 2017 |
| 05/02/2017 | Earnings | AMAG Pharmaceuticals Inc First Quarter Earnings in 2017 Release |
| 02/14/2017 08:00 EST | Misc | AMAG Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2016 |
| 02/14/2017 | Earnings | AMAG Pharmaceuticals Inc Fourth Quarter Earnings in 2016 Release |
| 11/03/2016 08:00 EDT | Misc | AMAG Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2016 |
| 11/03/2016 | Earnings | AMAG Pharmaceuticals Inc Third Quarter Earnings in 2016 Release |
| 08/09/2016 08:00 EDT | Misc | AMAG Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2016 |
| 08/09/2016 | Earnings | AMAG Pharmaceuticals Inc Second Quarter Earnings in 2016 Release |
AMAG Fundamentals
Income Statement View Statement
AMAG Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
AMAG One Page Reports
- One Page Report Download
AMAG Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 18.80 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.amagpharma.com
- Investor Relations URL: http://ir.amagpharma.com/phoenix.zhtml?c=61596&p=irol-irhome
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: May. 02, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: AMAG Pharmaceuticals Inc is a specialty pharmaceutical company with a focus on maternal health, anemia and cancer supportive care. The Company markets Makena; Feraheme, Injection for Intravenous (IV) use; and MuGard, Mucoadhesive Oral Wound Rinse.
AMAG Comparables
EditAMAG Excel Add-In Codes
- Name: =YCI("AMAG","name")
- Description: =YCI("AMAG","description")
- Sector: =YCI("AMAG","sector")
- Industry: =YCI("AMAG","industry")
- Est. Current Fiscal Year End: =YCI("AMAG","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other AMAG Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- AMAG Tweets Stocktwits
Advertisement
